BioCryst Pharmaceuticals (BCRX) Soars: Stock Adds 10.9% in Session

BioCryst Pharmaceuticals, Inc. (BCRX) was a big mover last session, as the company saw its shares rise by almost 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained roughly 36% since May 8.

This drug manufacturer has seen three positive and two negative estimate revisions over the last 30 days whiled its Zacks Consensus Estimate remained same over the same time frame, suggesting that more solid trading could be ahead for BioCryst Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

BioCryst Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Some better-ranked stocks in the same industry include Biomerica Inc. (BMRA), Cardiome Pharma Corp. (CRME) and POZEN Inc. (POZN). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report

BIOMERICA INC (BMRA): Free Stock Analysis Report

CARDIOME PHARMA CORP ORD (CRME): Free Stock Analysis Report

POZEN INC (POZN): Free Stock Analysis Report


Zacks Investment Research